Randomized Single-blind Placebo Controlled Comparative Trial of Pramipexole and Bromocriptine in Parkinson's Disease
Status:
Completed
Trial end date:
2004-08-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to investigate the efficacy and safety of Pramipexole Tablets
in patients with Parkinson's disease (who can be treated with L-DOPA concomitantly) in a
single blind, comparative method using Bromocriptine tablets as comparators (phase III
comparative trial)